Federal Grant money worth $18.1 million has been awarded to VCU or Virginia Commonwealth University for its tobacco study that will determine modified risks of threes products and other novel tobacco items like v2 electronic cigarettes.
Through this tobacco study, data may be gathered in developing a tool that the FDA and NIH can use to evaluate regulatory policy on tobacco products in the US. VCU is just one of the 14 large institutions chosen to partake in a research program.
What Researchers Will Do
VCU researchers from the College of Humanities and Sciences, Department of Psychology’s Center for the Study of Tobacco Products will be tasked to assess evaluation methods for modified risk tobacco products.
They will work in developing and testing a multi-disciplinary approach utilizing clinical behavior, engineering and random controlled trials in determining the effects of novelty tobacco products.
The University and the VCU Health System President Dr. Michael Rao stated that this is a historic grant for the academe that signifies they are a country wide leader for their distinctive dedication to health of mankind.
The co-principal investigators for this grant’s purpose are Dr. Robert Balster, VCU School of Medicine Pharmacology and Toxicology professor; and Dr. Thomas Eisenberg, VCU Clinical Behavioral Pharmacology Laboratory director and Psychology professor.
The two campuses of VCU that are involved in College of Humanities and Sciences: School of Medicine and Massey Cancer Center will be covered by the project.
Four components will be involved: assessment of influential factors to MRTP toxicant and nicotine yield, short term effects of MRTP and other products comparison, use/misuse of MRTP on the perceived effect, beliefs and attitude of the users and random control trial.
Center for the Study of Tobacco Products is actually focused on the novel tobacco products, but Eisenberg said that they are also allowed to provide more details about electronic cigarettes. The grant also allows them the capacity and flexibility to begin new studies that will tackle issues in the evolving market of tobacco.